TITLE

Prospective Study of Cigarette Smoking and Amyotrophic Lateral Sclerosis

AUTHOR(S)
Weisskopf, M. G.; McCullough, M. L.; Calle, E. E.; Thun, M. J.; Cudkowicz, M.; Ascherio, A.
PUB. DATE
July 2004
SOURCE
American Journal of Epidemiology;Jul2004, Vol. 160 Issue 1, p26
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Cigarette smoking has been proposed as a risk factor for amyotrophic lateral sclerosis (ALS), but because of the low incidence of ALS this association has been examined only with case-control methods. The authors prospectively assessed the relation between cigarette smoking and ALS mortality among participants in the Cancer Prevention Study II cohort of the American Cancer Society, a cohort of over 1 million people enrolled in 1982 who completed a lifestyle questionnaire including a detailed smoking history at baseline. Causes of deaths were ascertained through death certificates; ALS was not identified separately until 1989. From January 1, 1989, through 1998, 291 women and 330 men died from ALS. The relative risk of ALS among current smokers compared with never smokers was 1.67 (95% confidence interval: 1.24, 2.24; p = 0.002) in women and 0.69 (95% confidence interval: 0.49, 0.99; p = 0.04) in men. The difference in the relative risk estimates between the sexes was statistically significant (p < 0.0003). This large prospective study provides limited evidence that current cigarette smoking may be associated with increased death rates from ALS in women but not in men.
ACCESSION #
19670334

 

Related Articles

  • Vascular endothelial growth factor-A (VEGF-A) and chemokine ligand-2 (CCL2) in amyotrophic lateral sclerosis (ALS) patients. Gupta, Pawan K.; Prabhakar, Sudesh; Sharma, Suresh; Anand, Akshay // Journal of Neuroinflammation;2011, Vol. 8 Issue 1, p47 

    Background: Vascular endothelial growth factor-A (VEGF-A) and chemokne ligand-2 (CCL2) levels have been examined in Amyotrophic Lateral Sclerosis (ALS) patients in Western countries. We measured these values in North Indian ALS patients, since these patients display considerably enhanced...

  • Basic facts and figures. Wood-Allum, Clare; Shaw, Pamela // GP: General Practitioner;3/18/2002, p57 

    Focuses on motor neurone disease (MND), one of the three most common neurodegenerative diseases in adulthood. Age groups affected by the disease; Symptoms of amyotrophic lateral sclerosis, a subtype of MND; Other subtypes of the disease.

  • Motor Neurone Disease Australia. BERRY, EMI // Money (Australia Edition);Mar2015, Issue 176, p26 

    The article offers information on the Motor Neurone Disease Australia, which aims to promote optimal care for people with motor neurone disease (MND) and finance MND research.

  • Improving survival in amyotrophic lateral sclerosis: future treatments in a modern service. Hrastelj, James; Robertson, Neil // Journal of Neurology;Jul2015, Vol. 262 Issue 7, p1791 

    An introduction to the journal is presented where the editor discusses various reports published in the issue which includes the discovery of another gene associated with amyotrophic lateral sclerosis (ALS), the association between methylation of the C9orf72 promoter and disease severity and the...

  • A zebrafish model exemplifies the long preclinical period of motor neuron disease. Ramesh, Tennore M.; Shaw, Pamela J.; McDearmid, Jonathan // Journal of Neurology, Neurosurgery & Psychiatry;Nov2014, Vol. 85 Issue 11, p1288 

    A letter to the editor is presented in response to the article "Amyotrophic lateral sclerosis: a long preclinical period?" by A. Eisen and colleagues published in a issue of 2014, is presented.

  • Response to a letter by Dr T Ramesh. Eisen, Andrew // Journal of Neurology, Neurosurgery & Psychiatry;Nov2014, Vol. 85 Issue 11, p1289 

    A response from the author of the article "Amyotrophic lateral sclerosis: a long preclinical period?" that was published in a issue of 2014 is presented.

  • Motor neurone disease. Shaw, Pamela J // BMJ: British Medical Journal (International Edition);04/24/99, Vol. 318 Issue 7191, p1118 

    Discusses the motor neurone disease, one of the most common neurodegenerative diseases of adult onset. Incidence of the disease; Pathogenesis of motor neurone disease; Treatment.

  • Erratum to: Caregiver burden in amyotrophic lateral sclerosis: a cross-sectional investigation of predictors. Burke, Tom; Elamin, Marwa; Galvin, Miriam; Gallagher, Laura; Hardiman, Orla; Pender, Niall // Journal of Neurology;Dec2015, Vol. 262 Issue 12, p2799 

    A correction to the article "Caregiver Burden in Amyotrophic Lateral Sclerosis: A Cross-Sectional Investigation of Predictors," in a 2015 issue of the "Journal of Neurology" is presented.

  • Interpreting change scores on the Amyotrophic Lateral Sclerosis Assessment Questionnaire (ALSAQ-40). Jenkinson, C; Peto, V; Jones, G; Fitzpatrick, R // Clinical Rehabilitation;Jul2003, Vol. 17 Issue 4, p380 

    Objectives: To determine the amount of change over time on the five dimensions of the 40-item Amyotrophic Lateral Sclerosis Assessment Questionnaire (ALSAQ-40) that are subjectively meaningful to patients. Minimally important differences (MID), effect sizes (ES) and standardized response means...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics